Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3469
+0.01013.00%
Post-market: 0.37000.0231+6.66%19:03 EDT
Volume:634.79K
Turnover:216.63K
Market Cap:24.66M
PE:-0.93
High:0.3500
Open:0.3500
Low:0.3245
Close:0.3368
Loading ...
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report
Apr 29, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 19, 2021

Major Issues Report

8-K - Current report
Apr 19, 2021

Major Issues Report

8-K - Current report
Apr 15, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 09, 2021

Major Issues Report

8-K - Current report
Apr 01, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

Major Issues Report

8-K - Current report
Mar 18, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 03, 2021

Major Issues Report

8-K - Current report
Mar 03, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals